LV10717B - Triazolopyrimidine derivatives, method for preparation thereof, pharmaceutical compositions containing them, methods for preparing these compositions - Google Patents
Triazolopyrimidine derivatives, method for preparation thereof, pharmaceutical compositions containing them, methods for preparing these compositions Download PDFInfo
- Publication number
- LV10717B LV10717B LVP-94-60A LV940060A LV10717B LV 10717 B LV10717 B LV 10717B LV 940060 A LV940060 A LV 940060A LV 10717 B LV10717 B LV 10717B
- Authority
- LV
- Latvia
- Prior art keywords
- methyl
- formula
- propyl
- triazolo
- biphenylyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9108486A FR2678618B1 (fr) | 1991-07-05 | 1991-07-05 | Nouveaux derives de triazolo pyrimidine antagonistes des recepteurs a l'angiotensine ii; leurs procedes de preparation, compositions pharmaceutiques les contenant. |
Publications (2)
Publication Number | Publication Date |
---|---|
LV10717A LV10717A (lv) | 1995-06-20 |
LV10717B true LV10717B (en) | 1995-12-20 |
Family
ID=9414783
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
LVP-94-60A LV10717B (en) | 1991-07-05 | 1994-03-29 | Triazolopyrimidine derivatives, method for preparation thereof, pharmaceutical compositions containing them, methods for preparing these compositions |
Country Status (23)
Country | Link |
---|---|
US (1) | US5217973A (ja) |
EP (1) | EP0521768B1 (ja) |
JP (1) | JP3140566B2 (ja) |
KR (1) | KR100243628B1 (ja) |
AT (1) | ATE101153T1 (ja) |
AU (1) | AU655288B2 (ja) |
CA (1) | CA2072233C (ja) |
CZ (1) | CZ284757B6 (ja) |
DE (1) | DE69200045T2 (ja) |
DK (1) | DK0521768T3 (ja) |
EE (1) | EE03003B1 (ja) |
ES (1) | ES2063570T3 (ja) |
FR (1) | FR2678618B1 (ja) |
HU (2) | HU220225B (ja) |
IE (1) | IE65635B1 (ja) |
IL (1) | IL102367A (ja) |
LV (1) | LV10717B (ja) |
MD (1) | MD523G2 (ja) |
NZ (1) | NZ243443A (ja) |
RU (1) | RU2103270C1 (ja) |
SK (1) | SK279902B6 (ja) |
TW (1) | TW221445B (ja) |
ZA (1) | ZA924954B (ja) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5358950A (en) * | 1991-07-05 | 1994-10-25 | Laboratoires Upsa | Triazolopyrimidine derivatives which are angiotensin II receptor antagonists |
FR2687677B1 (fr) * | 1992-02-24 | 1996-10-11 | Union Pharma Scient Appl | Nouveaux derives de polyazaindenes antagonistes des recepteurs a l'angiotensine ii ; leurs procedes de preparation, compositions pharmaceutiques les contenant. |
US5389632A (en) * | 1992-02-24 | 1995-02-14 | Laboratoires Upsa | Pyrazolopyrimidine derivatives which are angiotensin II receptor antagonists |
US5387747A (en) * | 1992-02-24 | 1995-02-07 | Laboratoires Upsa | Triazolopyrimidine derivatives which are angiotensin II receptor antagonists, their methods of preparation and pharmaceutical compositions in which they are present |
IT1263804B (it) * | 1993-01-22 | 1996-09-03 | Luso Farmaco Inst | Derivati pirimidinonici fusi con eterocicli azotati ad attivita' a ii antagonista |
US5358947A (en) * | 1993-09-13 | 1994-10-25 | American Cyanamid Company | Angiotensin II receptor blocking 2,3-substituted pyrazolo[1,5-a]-1,3,5-triazin-4(3H)-ones |
EP0976753B1 (en) * | 1997-03-24 | 2004-01-02 | Kyowa Hakko Kogyo Co., Ltd. | [1,2,4]TRIAZOLO[1,5-c]PYRIMIDINE DERIVATIVES |
SE9903028D0 (sv) | 1999-08-27 | 1999-08-27 | Astra Ab | New use |
US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
AU2008261102B2 (en) | 2007-06-04 | 2013-11-28 | Bausch Health Ireland Limited | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
GB0719803D0 (en) | 2007-10-10 | 2007-11-21 | Cancer Rec Tech Ltd | Therapeutic compounds and their use |
EP2328910B1 (en) | 2008-06-04 | 2014-08-06 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
WO2009158309A2 (en) * | 2008-06-25 | 2009-12-30 | Ligand Pharmaceuticals Inc. | Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
EP3241839B1 (en) | 2008-07-16 | 2019-09-04 | Bausch Health Ireland Limited | Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders |
US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
WO2014151206A1 (en) | 2013-03-15 | 2014-09-25 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase and their uses |
AU2014235209B2 (en) | 2013-03-15 | 2018-06-14 | Bausch Health Ireland Limited | Guanylate cyclase receptor agonists combined with other drugs |
BR112015030326A2 (pt) | 2013-06-05 | 2017-08-29 | Synergy Pharmaceuticals Inc | Agonistas ultrapuros de guanilato ciclase c, método de fabricar e usar os mesmos |
CA3235663A1 (en) * | 2021-10-19 | 2023-04-27 | Impact Therapeutics (Shanghai), Inc. | Substituted triazoloheteroaryl compounds as usp1 inhibitors and the use thereof |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US269980A (en) * | 1883-01-02 | Horse power | ||
GB859287A (en) * | 1958-10-03 | 1961-01-18 | Ici Ltd | Triazolopyrimidine derivatives and their preparation |
GB897870A (en) * | 1959-06-15 | 1962-05-30 | Ici Ltd | s-triazolo[2, 3-c]pyrimidine derivatives |
GB951652A (en) * | 1960-06-28 | 1964-03-11 | Wallace Broadbent | Sulphamyl triazolopyrimidines and their preparation |
US4269980A (en) * | 1979-12-17 | 1981-05-26 | American Cyanamid Company | (Substituted-phenyl)-1,2,4-triazolo[4,3-c]pyrimidines and (substituted-phenyl)-1,2,4-triazolo[1,5-c]pyrimidines |
US4572910A (en) * | 1983-03-03 | 1986-02-25 | Riker Laboratories, Inc. | Triazolo[1,5-c]pyrimidines substituted by nitrogen-containing heterocyclic rings |
US4528288A (en) * | 1983-05-02 | 1985-07-09 | Riker Laboratories, Inc. | Substituted triazolo[1,5-c]pyrimidines |
US4532242A (en) * | 1983-05-02 | 1985-07-30 | Riker Laboratories, Inc. | Substituted triazolo[4,3-c]pyrimidines |
US4562192A (en) * | 1984-02-03 | 1985-12-31 | G. D. Searle & Co. | 6-Substituted-5-phenyltetrazolo[1,5-a][1,2,4]triazole[1,5-c]pyrimidines, and pharmaceutical compositions containing them |
US4728652A (en) * | 1985-05-20 | 1988-03-01 | E. R. Squibb & Sons, Inc. | 2-substituted thio or oxy-4-aryl or heterocyclo-5-carboxy-1,4-dihydropyrimidines, composition containing them, and method of using them to reduce blood pressure |
US5010195A (en) * | 1988-05-25 | 1991-04-23 | The Dow Chemical Company | Herbicidal alkoxy-1,2,4-triazolo(1,5-c)primidine-2-sulfonamides |
US5073566A (en) * | 1989-11-30 | 1991-12-17 | Eli Lilly And Company | Angiotensin ii antagonist 1,3-imidazoles and use thereas |
EP0435827A3 (en) * | 1989-12-28 | 1991-11-13 | Ciba-Geigy Ag | Diaza compounds |
JPH05505609A (ja) * | 1990-03-30 | 1993-08-19 | メルク・エンド・カムパニー・インコーポレーテツド | 置換ピリミジン、ピリミジノンおよびピリドリミジン |
US5177206A (en) * | 1991-10-08 | 1993-01-05 | Dowelanco | Process for the preparation of substituted N-(aryl)-1,2,4-triazolopyrimidine-2-sulfonamides |
-
1991
- 1991-07-05 FR FR9108486A patent/FR2678618B1/fr not_active Expired - Lifetime
- 1991-08-07 US US07/741,134 patent/US5217973A/en not_active Expired - Lifetime
-
1992
- 1992-06-24 CA CA002072233A patent/CA2072233C/en not_active Expired - Lifetime
- 1992-06-30 AT AT92401850T patent/ATE101153T1/de active
- 1992-06-30 ES ES92401850T patent/ES2063570T3/es not_active Expired - Lifetime
- 1992-06-30 EP EP92401850A patent/EP0521768B1/fr not_active Expired - Lifetime
- 1992-06-30 DE DE69200045T patent/DE69200045T2/de not_active Expired - Lifetime
- 1992-06-30 DK DK92401850.0T patent/DK0521768T3/da active
- 1992-06-30 IL IL102367A patent/IL102367A/xx not_active IP Right Cessation
- 1992-07-01 IE IE922015A patent/IE65635B1/en not_active IP Right Cessation
- 1992-07-02 SK SK2078-92A patent/SK279902B6/sk not_active IP Right Cessation
- 1992-07-02 AU AU19396/92A patent/AU655288B2/en not_active Expired
- 1992-07-02 CZ CS922078A patent/CZ284757B6/cs not_active IP Right Cessation
- 1992-07-03 RU SU5052543A patent/RU2103270C1/ru active
- 1992-07-03 ZA ZA924954A patent/ZA924954B/xx unknown
- 1992-07-03 NZ NZ243443A patent/NZ243443A/xx not_active IP Right Cessation
- 1992-07-03 HU HU9202227A patent/HU220225B/hu unknown
- 1992-07-04 TW TW081105325A patent/TW221445B/zh not_active IP Right Cessation
- 1992-07-04 KR KR1019920011916A patent/KR100243628B1/ko not_active IP Right Cessation
- 1992-07-06 JP JP04200200A patent/JP3140566B2/ja not_active Expired - Lifetime
-
1994
- 1994-03-29 LV LVP-94-60A patent/LV10717B/en unknown
- 1994-11-22 EE EE9400308A patent/EE03003B1/xx unknown
- 1994-12-30 MD MD95-0084A patent/MD523G2/ro active IP Right Grant
-
1995
- 1995-06-27 HU HU95P/P00446P patent/HU211473A9/hu unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
LV10717B (en) | Triazolopyrimidine derivatives, method for preparation thereof, pharmaceutical compositions containing them, methods for preparing these compositions | |
ES2293064T3 (es) | 6-alcoxi-pirido-pirimidinas como inhibidores de la p-38 map quinasa. | |
EP2385053B1 (en) | Intermediates for the preparation of fused bicyclic mTOR inhibitors | |
AU2005299421B2 (en) | Compounds and compositions as inhibitors of Cannabinoid Receptor 1 activity | |
ES2388881T3 (es) | Azolopirimidinas como inhibidores de la actividad cannabinoide 1 | |
KR20020038963A (ko) | P38 단백질 키나제 저해제로서 헤테로알킬아미노-치환된이환 질소 헤테로환 | |
CA2653529A1 (en) | Pyridinone and pyridazinone derivatives as inhibitors of poly(adp-ribose)polymerase (parp) | |
HRP20030485A2 (en) | METHODS OF TREATING p38 KINASE-ASSOCIATED CONDITIONS AND PYRROLOTRIAZINE COMPOUNDS USEFUL AS KINASE INHIBITORS | |
RU2601410C1 (ru) | {3-[(7H-ПИРРОЛО[2,3-d]ПИРИМИДИН-4-ИЛ)АЗОЛИЛ]АЗЕТИДИН-3-ИЛ}АЦЕТОНИТРИЛЫ В КАЧЕСТВЕ ИНГИБИТОРОВ ЯНУС КИНАЗ | |
US20070049597A1 (en) | p38 MAP kinase inhibitors and methods for using the same | |
IE912114A1 (en) | Novel pyrimidine derivatives which are angiotensin ii¹receptor antagonists, their methods of preparation and¹pharmaceutical compositions in which they are present | |
US5231094A (en) | Triazolopyrimidines which are angiotensin II receptor antagonists and pharmaceutical compositions in which they are present | |
Nicolai et al. | Synthesis and SAR studies of novel triazolopyrimidine derivatives as potent, orally active angiotensin II receptor antagonists | |
CA2128876C (en) | Triazolopyrimidine derivatives as angiotensin ii receptor antagonists | |
Ahmed et al. | Fusions of pyrido [4′, 3′: 4, 5] thieno [2, 3‐d] pyrimidines with N‐heterocyclic moieties | |
US5358950A (en) | Triazolopyrimidine derivatives which are angiotensin II receptor antagonists | |
CA1051887A (en) | Triazolo (4,3-d) (1,4) benzodiazepine-3,6-diones | |
JPH069638A (ja) | ピラゾロピリミジン誘導体 | |
Twomey | Nucleophilic Cleavage of s-Triazolophthalazinone Derivatives | |
EP0000382A1 (en) | Pyrimido (4,5-c)pyridazines, compositions containing them and processes for their preparation |